InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Clearance for Depression and Suicidality Trial May 8, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by financialcontent. Read more Source: https://www.financialcontent.com/article/nnwire-2026-5-7-investornewsbreaks-nrx-pharmaceuticals-inc-nasdaq-nrxp-receives-fda-clearance-for-depression-and-suicidality-trial
